Hoehn and Yahr scale
Hoehn and Yahr Scale: Monitoring Parkinson's Disease Progression
The Hoehn and Yahr scale stands as one of the foremost systems for categorizing the progression of symptoms in patients with Parkinson's disease. Established to provide a consistent method to evaluate and communicate the severity of symptoms and stages of the disease, it has become a pivotal tool for clinicians around the world.
Historical Background
The Hoehn and Yahr scale was conceived by Margaret Hoehn and Melvin Yahr, and was originally published in 1967 in the esteemed journal Neurology. Their seminal work sought to define distinct stages of the disease, providing a spectrum ranging from stage 1 to stage 5, with each stage representing increasing severity and complexity of symptoms[1].
Scale Description
- Stage 1: Symptoms are unilateral (affecting only one side of the body).
- Stage 1.5: Unilateral involvement with involvement of neck and spine; characterized by a reduced swing of one arm.
- Stage 2: Symptoms become bilateral but there is no impairment of balance.
- Stage 2.5: Mild bilateral disease with recovery on pull test.
- Stage 3: Balance impairment becomes evident, but patients are still fully independent.
- Stage 4: Severe disability, but the patient can still walk or stand unassisted.
- Stage 5: Patients become wheelchair-bound or bedridden unless assisted.
Modified Hoehn and Yahr Scale
Given the complexity and diverse presentation of Parkinson's disease, researchers identified the need for more granular stages to accurately capture the disease's intermediate progression. As a result, stages 1.5 and 2.5 were integrated into the scale. These additions serve to bridge the gaps between the original stages, providing clearer insight into the disease's progression[2].
Clinical Relevance and Use
The Hoehn and Yahr scale, due to its simplicity and clarity, remains a popular tool for evaluating Parkinson's disease. While it does not encompass all the potential symptoms and issues faced by patients, it provides a straightforward and consistent method for gauging disease progression, which is invaluable for both clinical practice and research.
References
- ↑ Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: onset, progression and mortality. Neurology, 17(5), 427-442.
- ↑ Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., ... & Seidl, L. (2004). Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Movement disorders, 19(9), 1020-1028.
| This article is a stub. You can help WikiMD by registering to expand it. |
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD